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Hemophilic Pseudotumors: Diagnosis and Management
Abstract
Prevention is essential for avoiding the complications of muscle hematomas (pseudotumors, compartment syndromes 
and peripheral nerve lesions) in hemophilic patients. This is achieved through early diagnosis of muscle hematomas 
and proper long-term hematological treatment until they have resolved (confirmed by image studies). Ultrasound-guided 
percutaneous drainage could be beneficial in terms of achieving better and faster symptom relief. When suspecting 
a hemophilic pseudotumor, biopsy will help us confirm the diagnosis and rule out true tumors (chondrosarcoma, 
liposarcoma, synovial sarcoma) that sometimes mimic hemophilic pseudotumor. Surgical removal of hemophilic 
pseudotumor is the best solution. As alternatives, there are curettage and filling with cancellous bone and radiotherapy 
(when surgery is contraindicated). Preoperative arterial embolization (ideally 2 weeks before surgery) helps control 
intraoperative bleeding during surgery for giant pelvic pseudotumors.
Level of evidence: III
Keywords: Hemophilia, Muscle hematomas, Prevention, Pseudotumors, Treatment
Introduction
The clinical severity of hemophilia is commonly related to the plasma level of factor VIII or factor IX. Patients are classified as having mild, 
moderate or severe hemophilia depending on the level 
of the deficient factor, which can be >5% of normal in 
mild cases and <1% of normal in severe hemophilia. 
This is reflected in the frequency and causes of 
bleeding. Whereas a patient with mild hemophilia 
will bleed rarely, usually only after significant trauma 
or surgery, those with severe hemophilia may have 
several episodes per month, and typically bleed 
spontaneously as a result of minimal trauma or 
activities of daily living (1, 2).
The main problem for patients with hemophilia is that 
they suffer from hemorrhages in the musculoskeletal 
system, both joints (hemarthrosis) and muscles. These 
represent approximately 80% of all hemorrhages and 
usually begin in childhood. At the joint level, they 
usually occur mainly in the knees, ankles and elbows; 
at the muscular level, they can appear in any muscle 
group of the body (although muscle hematomas are 
less frequent than hemarthroses) (1, 2).
The most accepted treatment for muscle hematomas in 
patients with congenital coagulopathies is intravenous 
infusion of the deficient factor until achieving total 
spontaneous resorption of the hematoma (confirmed 
by imaging studies – ultrasonography-US, computed 
tomography-CT or magnetic resonance imaging-
MRI). Ultrasound-guided percutaneous drainage 
could be beneficial in terms of achieving better and 
faster symptom relief. Ultrasound guided hematoma 
evacuation is a safe procedure. However, the proportion 
of unsuccessful drainages and hematoma recurrence 
is substantial (13%). Such a rate of unsuccessful 
evacuation is due to excessive density and/or viscosity 
of the content. Ideally, hematoma drainage must be 
performed before 3 to 5 days since the beginning of 
the muscular bleed (3). However, when treatment 
is insufficient, some muscle hematomas can cause 
serious complications such as acute compartment 
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reviewed.
Hemophilic pseudotumors: Definition and 
epidemiology
A pseudotumor is a recurrent chronic muscle 
hematoma, which in patients with hemophilia ends up 
developing the form of a tumor [Figure 1]. It is essential 
to remember that when there is a suspicion of a 
pseudotumor in a patient with congenital coagulopathy, 
we must always rule out the existence of a true tumor, 
which can be achieved through exhaustive study of the 
case (diagnostic imaging) and ultimately by performing 
a biopsy (always according to tumour criteria and under 
adequate hemostatic control). Ideally, this type of injury 
should be treated in specialized centres with expertise 
in bleeding disorder management in collaboration with 
a “Bone Tumor Unit”.
When pseudotumors are large, they can compress 
neighboring anatomical structures. The most frequent 
is the pelvic pseudotumor, secondary to a hematoma of 
the iliopsoas muscle [Figures 2; 3] (4).
Another form of pseudotumor is a bone cyst, which is 
considered secondary to bleeding within a bone cavity. 
These lesions can be controlled by curettage and filling 
with bone graft or other similar material, provided that 
the bone cortices are intact [Figure 4].
In one study, 49 cystic lesions were analyzed in 37 
hemophilic patients (10). Their average age was 23 years 
and the mean follow-up was 10 years. The locations of 
the lesions were as follows: 24 (49%) in the tibia, seven 
(14.4%) in the ulna, six (12.2%) in the talus (12.2%), 
five (10.2%) in the humerus, five in the femur (10.2%) 
and two (4%) in distal radius. After aspirating the 
syndrome (ACS), pseudotumor and peripheral nerve 
compression (1-9). 
Patients with congenital coagulopathies may suffer 
from ACS due to a hematoma in some inextensible 
compartment of their anatomy. It is a rare problem 
but can be very serious. Typically, the ACS of the volar 
aspect of the forearm (Volkmann’s syndrome) causes a 
retraction of the volar musculature that causes a great 
deformity and permanent disability of the hand. It is 
essential to carry out the urgent opening of the affected 
compartment (fasciotomy) as soon as its existence is 
suspected (5, 7).
ACS is characterised by an increase in intramuscular 
pressure in an anatomical compartment. This causes 
a decrease in capillary perfusion that threatens tissue 
survival (5, 7). If the pressure increase lasts a few hours, 
there will be necrosis of the muscle and nerve tissue 
which will cause a contracture of the affected limb and 
a permanent loss of function. Therefore, early diagnosis 
and treatment is essential.
The diagnosis should be based on the clinical 
examination (intense pain when the affected muscles 
are stretched) and objective measurement of the limb 
perfusion pressure (diastolic blood pressure minus 
intramuscular pressure) in the affected compartment. 
To achieve a reliable diagnosis, the patient should be 
evaluated for 1-2 hours. In children and in patients with 
loss of consciousness, a diagnosis cannot be made based 
on the level of pain, so it will be essential to measure 
the pressure of the compartment. If the mean perfusion 
pressure of the limb measured during a 12-hour period 
(monitored every 1-2 hours) is less than 30 mmHg, 
fasciotomy should be performed. 
Unfortunately, fasciotomy is not exempt from potential 
complications. These include the need for further 
surgery because of a delay in the healing of the surgical 
wound, the need for a skin graft, pain, esthetic problems, 
nerve injury, permanent muscle weakness and chronic 
venous insufficiency. 
In hemophilia, the first step in the treatment of an 
ACS should be adequate substitution of the deficient 
coagulation factor (intravenous infusion). In some 
patients with congenital coagulopathies, it is possible 
to halt disease progression by means of appropriate 
hematological treatment, leaving surgery (fasciotomy) 
reserved for those cases in which, despite said 
hematological treatment, the ACS does not remit (5, 7).
Peripheral nerve lesions are infrequent in patients 
with congenital coagulopathies. The most common 
injury is to the femoral nerve (due to an iliopsoas 
muscle hematoma) (6). A case of entrapment of the 
peroneal nerve secondary to a muscle hematoma, and 
a combined nerve injury (severe in the median nerve, 
mild in the ulnar nerve) in a young hemophilic patient 
secondary to a hematoma on the forearm has also been 
described (8, 9). Hematological treatment is sometimes 
enough. Otherwise, surgical neurolysis of the affected 
nerve must be performed. Surgery would only be 
indicated if the problem is not resolved within 24 hours. 
In this article, the literature on the management of 
pseudotumors in patients with hemophilia will be 
Figure 1. Radiograph of a pseudotumor of the tibia (arrow) 
secondary to a recurrent muscle hematoma in the area.
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cystic content, the cavity was filled with impacted coral 
hydroxyapatite. In 48 of the 49 cases bone structure 
was restored, with only one patient needing a second 
intervention to resolve the problem.
Treatment of hemophilic pseudotumors
The best treatment for pseudotumor in patients 
with congenital coagulopathies is prevention, that is, 
proper long-term hematological treatment of muscle 
hematomas, until total resolution (reabsorption). 
Imaging tests (US, CT scan, MRI) are fundamental 
for monitoring the evolution of muscle hematomas 
in patients with congenital coagulopathies. In most 
cases the best solution is radical surgical excision. 
Preoperative arterial embolization (ideally 2 weeks 
before surgery) may be helpful in giant pelvic 
pseudotumors (11-13).
It has been observed that with primary hematological 
prophylaxis, the rate of pseudotumor has diminished 
considerably, being an indirect measure of the quality 
of a country’s hematological prophylaxis. It is essential 
to avoid muscle hematomas and diagnose them early. 
An untreated hematoma will tend to destroy adjacent 
soft tissues, erode the surrounding bone, and produce 
neurological damage (such as femoral nerve injury 
in hematomas of the iliopsoas muscle). It must be 
remembered that a pain in the right iliac fossa in a 
patient with congenital coagulopathy may be due to an 
iliopsoas hematoma and not to an acute appendicitis.
The combination of hematological treatment and 
radiotherapy can be used in pseudotumors located in 
the distal parts of the extremities, especially when there 
is a contraindication for surgery. Radiation should be 
done in small doses of 2 Gy or less until a total dose 
of 6-23.5 Gy is reached, which is the recommended 
radiation dosage (13).
Surgical treatment of pseudotumors should be 
performed in centers specialized in congenital 
coagulopathies and by a multidisciplinary team 
(hematologists, orthopedic surgeons, etc.). The main 
postoperative complications are infection, fistulation, 
pathological fractures (which may sometimes require 
amputation of the affected extremity) and even the 
death of the patient.
Table 1 summarises the most important publications in 
the literature on hemophilic pseudotumors (10, 14-54).
True tumors that mimic hemophilic pseudotumors
Sometimes we can find true tumours that mimic 
hemophilic pseudotumors, such as chondrosarcoma, 
liposarcoma, and synovial sarcoma (55, 56). A series 
of six cases in which surgery was performed under 
the diagnosis of pseudotumor has been published, 
confirming that they were actually malignant primary 
neoplasms (57). 
Other authors have published the case of a hemophilic 
patient who suffered a pathological fracture of the tibia. 
This fracture was presumably due to a pseudotumor but 
later confirmed to be due to non-Hodgkin’s lymphoma 
(58). The patient unfortunately died. The first known case 
of a giant gluteal neurofibroma in a 22-year-old hemophilic 
patient has also been published, which was resolved with 
satisfactory results by surgical removal (59).
The prevention of pseudotumors is fundamental. 
This is achieved through accurate diagnosis of muscle 
hematomas and proper long-term hematological 
Figure 2. Ultrasound image of an iliopsoas muscle hematoma 
(arrow) in a patient with hemophilia.
Figure 3. CT scan of an iliopsoas muscle hematoma in a hemophilic 
patient.
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Figure 4. Pseudotumor (bone cyst) of the proximal tibia successfully treated by curettage and filling with cancellous bone: (a) preoperative 
anteroposterior radiograph of the cyst (arrow); (b) postoperative anteroposterior radiograph.
(a) (b)
Table 1. Main data on hemophilic pseudotumors in the literature
AUTHORS YEAR FINDINGS
Hampton et al 
(16) 1990
These authors reported a patient with mild hemophilia who developed a pelvic pseudotumor that was successfully 
treated with surgery with no evidence of recurrence five years after operation.
Marisavljević 
et al (17) 1991
This article dealt with the successful extirpation of a femoral pseudotumor in a 53-year-old patient with 
severe hemophilia A and an inhibitor to factor VIII. A pseudotumor measuring 15 cm in diameter was extirpated. 
Heim et al (18) 1997 A 13-year-old boy with severe hemophilia presented with gross swelling of his foot and infrapatellar area. X-rays revealed two separate pseudotumors. The patient underwent a transfemoral amputation.
Maliekel et al 
(19) 1997
In this report, the authors described an elderly woman who required surgical excision of a large 
hemophilic pseudotumor adjacent to the left gluteal muscle. The pseudotumor was surgically removed. During an 
18-month follow-up period there has been no recurrence of bleeding or of the pseudotumor.
Ishiguro et al 
(20) 1998
This report presented three surgical cases of pseudotumors involved in a pathological fracture in the extremities. All 
cases showed a favourable postoperative course. 
Heeg et al (21) 1998
The authors reported the case of a patient with a hemophilic pseudotumor of the ilium who developed chronic 
fistulation, 6 months after en-bloc resection. During the initial resection, the large defect in the iliac wing was filled 
with bone cement, which may have contributed to formation of the fistula. A second surgical procedure consisted of 
excision of the fistula and bone cement and the dead space was obliterated by bringing the gluteus medius muscle into 
the defect. The fistula recurred, however. Re-excision of the fistula and obliteration of the dead space by a pedicled 
rectus abdominis muscle flap resulted in eradication of the fistula. These authors emphasized the importance of 
obliterating the dead space that results from large pseudotumor resection. The use of bone cement was not advocated. 
They concluded that if a fistula does occur, a pedicled rectus abdominis muscle flap may be considered.
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Sevilla et al 
(22) 1999
The authors presented a case of hemophilic pseudotumor of the iliac and caecum with cutaneous fistulas, with a 
septic process of endogenous origin. It was treated with surgical resection after performing arterial embolization to 
reduce the pseudotumor’s vascularization, thereby reducing its size and the risk of bleeding complications during 
surgery.
Raj et al (23) 1999 The authors reported a case of a hemophilic pseudotumor in the bony nasal pyramid, and believed this case was also unique on account of it having occurred in a patient with mild hemophilia. 
Heaton et al 
(24) 2000
Two cases of iliopsoas hemophilic pseudotumors were presented by these authors. In one patient, a fistula developed 
between a pseudotumor and the large bowel. This resulted in an abscess involving the pseudotumor and adjacent 
tissues. It resolved after 5 years of therapy involving percutaneous drainage and closure of the fistula. The second 
patient had a massive pseudotumor that had obstructed both ureters. Later he suffered fatal mixed Gram negative 
septicaemia probably related to erosion into the colon.
Sagarra et al 
(25) 2000
Surgical or percutaneous treatment and refilling with fibrin sealant was shown to be successful in a 19-year-old male 
with severe hemophilia B. The pseudotumor, in the upper pad of the left leg, was filled with hydroxyapatite after 
surgery. The authors suggested that the use of hydroxyapatite is a new and useful option in the surgical treatment of 
hemophilic pseudotumor.
Bellinazzo et al  
(26) 2000
The authors reported 4 pseudotumors of the ilium in hemophilia treated by means of exeresis and transposition 
of the omentum in the residual cavity The long follow-up of these four patients suggested that this procedure was 
feasible and curative; local bleeding, infection and fistulation did not recur and the patients remained ambulant with 
the aid of appropriate devices.
Kale et al (27) 2001 The authors presented imaging findings of a histopathologically proven mandibular hemophilic pseudotumor. 
Wexler et al 
(28) 2001
The authors reported a case of a proximal pseudotumor occurring in a 36-year-old patient with mild von Willebrand 
disease who made a good recovery with conservative management. 
Gupta et al  
(29) 2001
A case of pseudotumor of the paranasal sinuses occurring in a patient with hemophilia A was reported by these 
authors. There was a favorable response to combined treatment with radiation therapy and factor VIII replacement.
O’Connell et al 
(30) 2002
The authors documented the first successful report of the surgical resection of a massive pseudotumor in a patient 
with high responding FVIII inhibitors. 
Stevenson  and 
Keast (31) 2002
The authors described a case of epistaxis due to a mass in the maxillary antrum that when biopsied had the histological 
appearance of a hemophilic pseudotumor. The epistaxis was eventually controlled by external beam radiotherapy to 
the pseudotumor. 
Eby et al (32) 2002
The authors reported a 41-year-old patient with type 3 von Willebrand disease who underwent incomplete 
resection of a large retroperitoneal pseudocyst in 1995 and presented with a recurrent, extensive right abdominal 
and flank mass and signs and symptoms of large bowel obstruction. He required emergency partial colectomy for 
bowel ischaemia and removal of his right kidney, which was hydronephrotic due to prolonged ureteral obstruction 
by the pseudocyst. Following repeat partial resection of the pseudotumor, he developed persistent bleeding into 
the operative site despite aggressive administration of von Willebrand factor-rich factor VIII concentrates, resulting 
in retroperitoneal hematomas and abscesses, which resolved after 13 months of percutaneous drainage, extended 
supplementation of von Willebrand factor and antibiotic therapy.
Keller et al (33) 2002 The authors reported on a 45-year-old man with hemophilia A and high inhibitor titres who developed an extensive hemophilic pseudotumor with progressive destruction of the right ilium over a 12-year period. 
Takedani et al 
(34) 2004
The authors described a patient with hemophilia A and factor VIII inhibitor who underwent surgical excision of a 
large pseudotumor in the left femoral region. The pseudotumor was surgically removed. 
Libby and 
White (35) 2004 The authors present the fourth case describing intracranial pseudotumor in hemophilia.
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O’Dowd et al 
(36) 2006
The authors presented an extremely unusual presentation where a large hemophilic pseudotumor of the pelvis 
extended to impinge the adjacent colon, resulting in large bowel obstruction.
Valentino et al 
(14) 2006
The successful removal of the giant pseudotumor described in this case report was achieved by a multidisciplinary 
team and demonstrated that this approach, albeit associated with significant risk, may be curative.
Ahuja et al (37] 2007
The authors described the management of a young boy with mild hemophilia A and a massive iliac pseudotumor with 
a multi-modality approach involving factor replacement, radiation therapy, embolization and surgery. The patient 
was initially treated with recombinant factor VIII and radiation therapy. Because of inadequate response and 
worsening of bony erosion, the patient had a preoperative embolization followed by surgical excision. The surgical 
procedure was associated with minimal blood loss and the patient had a relatively smooth postoperative course 
with no physical morbidity. 
Rey et al (38) 2007 The authors reported three cases of pseudotumor of the mandible in young patients with mild hemophilia A.
Al Saadi et al 
(39) 2008
The authors presented the case of a 20-year-old male patient with a six-month history of left leg weakness, limited 
movement and muscle wasting. He was diagnosed clinically as having a psoas muscle rhabdomyosarcoma. During 
a CT-guided Tru-cut biopsy, he developed a serious and life-threatening bleed from a retroperitoneal muscular 
hematoma. The patient underwent laparotomy prior to his final diagnosis of an iliopsoas pseudotumor.
D’Young (40) 2009
Two cases were described where physiotherapy treatment was applied to large masses at the shoulder and femur 
respectively, where therapy commenced within the first 6 months following onset. These were presented relative to 
a case that was managed over a much longer period without early physiotherapy input, and the relative outcomes 
are examined. While both the early physiotherapy-managed cases showed a complete resolution at follow-up 
examination, the more established chronic pseudotumor required surgical excision, with significant residual muscle 
contractility, length and strength issues noted on clinical and MRI review. 
Toepfer et al 
(41) 2008
The authors presented the case of a 59-year-old male patient suffering from a hemophilic pseudotumor of the right 
distal femur. After verification of the diagnosis by means of an open biopsy, final surgery with curettage and plombage 
with bone cement was performed.
Shi et al (42) 2009 The authors presented imaging findings of a histopathologically proven hemophilic pseudotumor involving the left mandibular region in a 9-year-old Chinese boy.
Bernstaedt et 
al (43) 2009
The authors reported on two patients with hemophilic pseudotumors who did not respond to intensive factor 
replacement therapy. Therefore, the pseudotumors had to be removed surgically in both cases.
Petratos et al 
(44) 2009
The authors reported a case of a large pseudotumor in the right talus of an 11-year-old boy with severe hemophilia A. 
The described intraosseous lesion was treated with surgical curettage and autologous bone grafting. Twenty months 
after surgery, computed tomography scan showed no signs of recurrence. Forty months after surgery, radiological 
studies confirmed satisfactory incorporation of the graft and no evidence of bone growth disturbance. At the same 
time, he was able to fully participate in his daily activities, presenting painless and almost full range of motion of his 
right ankle joint.
Yoshitake et al 
(45) 2011
A hemophilic pseudotumor was identified in the mandible of a 5-year-old male with severe hemophilia A. The 
patient initially experienced painless swelling of the mandible. CT revealed a marked enlargement of the lower right 
mandibular border, which was associated with a low-density area, and irregular absorption of the lingual cortex bone. 
A malignant tumour was suspected and a biopsy was performed after the administration of coagulation factor (Factor 
VII). A histopathologic diagnosis of hemophilic pseudotumor was made and the patient subsequently underwent 
surgical treatment. A cavity was created in the multilocular bone cyst and surgical curettage and irrigation were 
performed with the same haemorrhagic control as in the biopsy procedure. The multilocular cyst was contained 
within a hematoma and was surrounded by thin granular tissue. Three years after surgery, no abnormal signs were 
detected by radiography during follow-up examinations. 
Liu et al (46) 2011
An HIV infected hemophilia patient with a huge inflammatory pseudotumor was severely ill. Right hip joint 
amputation was performed with perioperative infusion of coagulation factor VIII and highly active antiretroviral 
therapy (HAART). Pathology studies revealed inflammatory cell infiltration, formation of folliculus lymphaticus, 
muscular fibre breakage, fibrous tissue hyperplasia, and necrosis in both soft tissue and bone were seen in an 
inflammatory pseudotumor. The vital signs remained stable during the operation and patient’s overall health 
improved significantly ten months after operation. 
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Yang et al (47) 2012
 The authors reported three pediatric patients with histology-proven hemophilic pseudotumors arising from the
 maxillary bone. All three patients underwent CT and/or MRI. Combined with six previously reported cases in the
literature, the imaging features were comprehensively analyzed.
Panotopoulos
et al (48) 2012
 The authors reported six patients with hemophilic pseudotumors. The mean age at surgery was 45.9 (range, 40-61)
 years. The iliac bone was affected in three patients (one right, two left), the right tibia (distal diaphysis) in one, the
 right thigh in two and the right ulna (proximal part) in one patient. One patient had two pseudotumors. At the latest
follow-up after 8.4 (range, 4-24) years, normal healing with no recurrence was observed.
 Serban
et al (49) 2012
 The authors presented a 14-year follow-up of a patient with severe hemophilia A, treated sporadically with fresh
 plasma, cryoprecipitate and factor concentrates, who developed a giant iliopsoas pseudotumor. Since he was an infant
 with on-demand therapy with fresh frozen plasma, cryoprecipitate and low doses of factor concentrates, he presented
 many spontaneous bleeds, developing multiple disabling arthropathies. At the age of 14 years, an iliopsoas hematoma
 occurred, which relapsed several times, developing an iliopsoas pseudotumor. After 5 years, Klebsiella sepsis was
 diagnosed. A CT scan revealed a fistula between the pseudotumor and the gut. The sepsis improved on antibiotics,
 but over a period of 10 months, 5 episodes of hematemesis and melena, followed by one episode of macroscopic
 haematuria occurred; two months later he developed an inguino-crural mass which fistulised through the abdominal
 wall. After 108 hospitalization days and consumption of 104840 IU of factor VIII, he left the clinic in good condition.
 One year later, the temporary colostomy with anus stoma was closed. After almost 10 years, follow-up revealed a
favourable outcome. The patient was well, active within his family and profession.
Lim et al (50) 2014
 The authors described the clinical features and management of hemophilic pseudotumor by retrospectively reviewing
 the medical records of hemophilia patients with a diagnosis of pseudotumor seen at their Hemophilia Center from
 1981 to 2011. They identified 12 pseudotumors in 11 patients over a 30-year period. Six patients had known
 inhibitors or a history of inhibitor. An etiological antecedent leading to the development of pseudotumor was
 reported in nine cases. The location of the pseudotumor was confined to soft tissue (n = 3) and bone (n = 8). Six of the
 12 pseudotumors (50%) were not diagnosed at the time of initial presentation, with a delay ranging from 6 weeks to
 6 years. In eight cases, surgical intervention (surgical drainage, n = 2; excision, n = 4; limb amputation, n = 2) was the
 initial treatment, with complete resolution in six cases. Conservative management with close monitoring occurred in
 three cases, with one case subsequently requiring surgical resection.
Low et al (51) 2014
 The authors reported a case of a 43-year-old man with hemophilia A who presented with a gradually enlarging left
 thigh mass for 8 months. There were no constitutional symptoms. Plain radiograph showed an expansile lytic lesion
 with ‘soap-bubble’ appearance arising from the left femoral diaphysis. On MRI, it appeared as a non-enhancing,
 multilobulated lesion expanding the medullary and subperiosteal spaces. The mass exhibited a concentric ring
 sign with heterogeneous intermediate signal intensity in the core lesion, reflective of chronic hematoma with blood
 degradation products of different stages. A diagnosis of hemophilic pseudotumor was made. Hypercalcemia, however,
 raised a diagnostic dilemma as bone malignancy needed to be considered. An open excisional biopsy and subsequent
 amputation confirmed the diagnosis of osseous hemophilic pseudotumor. Nuclear medicine study later revealed a
concurrent parathyroid adenoma.
Kamal et al (52) 2014
 The authors reported on a 30-year-old hemophilic man with a pelvic pseudotumor compressing adjacent structures
 causing pain and swelling and destruction of surrounding soft tissues and bones. He underwent evacuation of
the pseudotumor, acetabular reconstruction using the Harrington procedure, and total hip arthroplasty.
 Purkait
et al (53) 2014
 This report described an 11-year-old boy with mild factor IX deficiency (17 % of normal factor IX activity), who
developed a pseudotumor of the femur.
 Caviglia
et al (10) 2015
 The aim of this study was to show the treatment of 10 pseudotumous in 7 patients with inhibitors. Eight were bone
 pseudotumors and two were soft tissue pseudotumors. Only one patient responded to conservative treatment.
 Surgery was performed on the others six patients, since their pseudotumors did not shrink to less than half their
 original size.
Dutt et al (54) 2015  In this case report, the authors described the natural history, clinical course and successful surgical management of apatient with hemophilia who presented with a massive pseudotumor.
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